Overview

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

Status:
Terminated

Trial end date:
2014-03-19

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if early ablation (i.e., ablation of ventricular tachycardia in patients with infrequent VT episodes) is more effective than medical therapy alone for the treatment of ischemic ventricular tachycardia in patients with Implantable Cardioverter Defibrillators (ICDs) who continue to have episodes of ventricular tachycardia despite drug therapy.

Phase:

Phase 4

Details

Lead Sponsor:

Biosense Webster, Inc.

Treatments:

Anti-Arrhythmia Agents